{"id":2818,"date":"2025-12-11T16:57:48","date_gmt":"2025-12-11T16:57:48","guid":{"rendered":"https:\/\/www.finznest.com\/blog\/stocks-making-the-biggest-moves-premarket-orcl-oxm-adbe-gemi\/"},"modified":"2025-12-11T16:57:48","modified_gmt":"2025-12-11T16:57:48","slug":"stocks-making-the-biggest-moves-premarket-orcl-oxm-adbe-gemi","status":"publish","type":"post","link":"https:\/\/www.finznest.com\/blog\/stocks-making-the-biggest-moves-premarket-orcl-oxm-adbe-gemi\/","title":{"rendered":"Stocks making the biggest moves premarket: ORCL, OXM, ADBE, GEMI"},"content":{"rendered":"<div>\n<div data-test=\"articleBody-2\" data-analytics=\"RegularArticle-articleBody-5-2\">\n<p><span hidden=\"\" aria-hidden=\"true\" class=\"ArticleBody-extraData\"><span hidden=\"\" aria-hidden=\"true\" class=\"ArticleBody-extraData\"><span hidden=\"\" aria-hidden=\"true\" class=\"xyz-data\">Check out the companies making headlines before the bell: Oracle \u2014 The software giant tumbled more than 12% after reporting fiscal second-quarter revenue that missed analyst expectations. Analysts across Wall Street raced to lower their price targets. Adobe \u2014 Shares fell slightly after the software company issued lackluster guidance for fiscal year 2026. Adobe sees earnings per share in a range of $23.30 to $23.50. Analysts polled by FactSet expected a forecast for $23.38 per share. Eli Lilly \u2014 A late-stage trial showed the company&#8217;s next-generation obesity drug, retatrutide, delivered what appears to be the highest weight loss yet while reducing knee arthritis pain. Shares moved 2% higher. Oxford Industries \u2014 The Tommy Bahama and Lilly Pulitzer parent tumbled 21.9% after the apparel maker gave weak current-quarter guidance and cut its full-year earnings outlook. Oxford said to expect between $2.20 and $2.40 in earnings per share, excluding items, in the year, while analysts polled by FactSet penciled in $2.90 per share. Gemini Space Station \u2014 Shares jumped 15% after the cryptocurrency exchange secured a license to offer prediction markets to its clients in the U.S. Visa \u2014 The payments stock rose 1% after Truist named Visa among its favorite names for 2026, calling it a &#8220;preferred quality compounder.&#8221; Corbus Pharmaceuticals \u2014 The biopharma company gained more than 7% after it reported results from a Phase 1a study that showed a treatment for obesity had a favorable safety profile and emerging evidence of weight loss. Planet Labs \u2014 The satellite imagery company surged more than 17% after Planet Labs posted third-quarter revenue of $81 million, which topped the LSEG consensus estimate of $72 million. \u2014 CNBC&#8217;s Michelle Fox, Alex Harring, Fred Imbert and Liz Napolitano contributed reporting<\/span><\/span><\/span><span class=\"HighlightShare-hidden\" style=\"top:0;left:0\"\/><\/p>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Check out the companies making headlines before the bell: Oracle \u2014 The software giant tumbled more than 12% after reporting fiscal second-quarter revenue that missed analyst expectations. Analysts across Wall Street raced to lower their price targets. Adobe \u2014 Shares fell slightly after the software company issued lackluster guidance for fiscal year 2026. Adobe sees [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":2819,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[1986,372,1607,371,373,912,1985,559,238],"class_list":["post-2818","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog","tag-adbe","tag-biggest","tag-gemi","tag-making","tag-moves","tag-orcl","tag-oxm","tag-premarket","tag-stocks"],"_links":{"self":[{"href":"https:\/\/www.finznest.com\/blog\/wp-json\/wp\/v2\/posts\/2818","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.finznest.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.finznest.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.finznest.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.finznest.com\/blog\/wp-json\/wp\/v2\/comments?post=2818"}],"version-history":[{"count":0,"href":"https:\/\/www.finznest.com\/blog\/wp-json\/wp\/v2\/posts\/2818\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.finznest.com\/blog\/wp-json\/wp\/v2\/media\/2819"}],"wp:attachment":[{"href":"https:\/\/www.finznest.com\/blog\/wp-json\/wp\/v2\/media?parent=2818"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.finznest.com\/blog\/wp-json\/wp\/v2\/categories?post=2818"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.finznest.com\/blog\/wp-json\/wp\/v2\/tags?post=2818"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}